Work

Ab0778 Association Between Patient-reported Outcomes and Disease Activity in Bimekizumab-treated Patients With Psoriatic Arthritis

Year: 2020

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2020-eular.4204

Authors: L. Gossec, P.J. Mease, A.B. Gottlieb, A. Ogdie, D. Assudani, J. Coarse, B. Ink, L.C. Coates

Institutions: Sorbonne Université, Pitié-Salpêtrière Hospital, University of Washington, Swedish Medical Center, Swedish Medical Center, Icahn School of Medicine at Mount Sinai, Hospital of the University of Pennsylvania, UCB Pharma (United Kingdom), UCB Pharma (United States), University of Oxford

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Eli Lilly and Company, Pfizer, Sanofi, Biogen, Celgene, Mylan, UCB Pharma

OpenAlex ID: W3125577461

Cites:

Cited by: 4

Related to: 10